AMBER GUY: Open Payments
NPI 1003524919 · CARLISLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 27 payments from 13 companies in 2025. Trend: 2023 $1,226 · 2024 $438 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $165 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Indivior Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $24 |
| Corcept Therapeutics | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Amgen Inc. | 1 | $17 |
Products named: MAVYRET, VRAYLAR, HETLIOZ, AUSTEDO XR, SUBLOCADE, AREXVY, Korlym, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
